LFG
IRMD icon

Larson Financial Group’s iRadimed IRMD Stock Holding History

Larson Financial Group’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.3K Sell
338
-73
-18% -$6.65K ﹤0.01% 1740
2026
Q1 		$39.5K Buy
411
+27
+7% +$2.7K ﹤0.01% 1474
2025
Q4 		$37.4K Buy
384
+23
+6% +$1.97K ﹤0.01% 1387
2025
Q3 		$25.7K Sell
361
-307
-46% -$20.5K ﹤0.01% 1498
2025
Q2 		$39.9K Buy
668
+624
+1,418% +$34.2K ﹤0.01% 1161
2025
Q1 		$2.31K Buy
44
+14
+47% +$787 ﹤0.01% 2121
2024
Q4 		$1.65K Buy
30
+15
+100% +$789 ﹤0.01% 1924
2024
Q3 		$754 Buy
+15
New +$692 ﹤0.01% 2048

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Larson Financial Group's IRMD Position: Q2 2026 in Review

Larson Financial Group reduced its iRadimed (IRMD) stake by 18% in Q2 2026, selling an estimated $6.65K and leaving 338 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1740.

Larson Financial Group first reported a position in IRMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $39.9K in Q2 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Larson Financial Group held 338 shares of iRadimed worth $32.3K as of Q2 2026.
  • Larson Financial Group sold 73 iRadimed shares in Q2 2026, an estimated $6.65K.
  • iRadimed made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1740 holding.
  • Larson Financial Group first reported a position in iRadimed in Q3 2024 and has held it in 8 quarters since.
  • Larson Financial Group's iRadimed position peaked at $39.9K in Q2 2025.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.